Kenneth M. Kozloff, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Molecular and Cellular Biomechanics, Organ and Whole Body Biomechanics, Tissue Engineering and Regenerative MedicineGoogle:
"Kenneth Kozloff"Mean distance: 9.03
Parents
Sign in to add mentorSteven A. Goldstein | grad student | 2005 | University of Michigan | |
(Influence of a collagen mutation of the mechanical nature of bone: Governing factors in a disease model for osteogenesis imperfecta type IV.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Surowiec RK, Battle LF, Schlecht SH, et al. (2020) Gene Expression Profile and Acute Gene Expression Response to Sclerostin Inhibition in Osteogenesis Imperfecta Bone. Jbmr Plus. 4: e10377 |
Cabral WA, Fratzl-Zelman N, Weis M, et al. (2020) Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia. Matrix Biology : Journal of the International Society For Matrix Biology |
Varga P, Willie BM, Stephan C, et al. (2020) Finite element analysis of bone strength in osteogenesis imperfecta. Bone. 133: 115250 |
Surowiec RK, Battle LF, Ward FS, et al. (2019) A Xenograft Model to Evaluate the Bone Forming Effects of Sclerostin Antibody in Human Bone Derived from Pediatric Osteogenesis Imperfecta Patients. Bone. 115118 |
Scheiber AL, Barton DK, Khoury BM, et al. (2019) Sclerostin Antibody-Induced Changes in Bone Mass are Site Specific in Developing Crania. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
Olvera D, Stolzenfeld R, Fisher E, et al. (2019) Pamidronate Administration during Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
Olvera D, Stolzenfeld R, Marini JC, et al. (2018) Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
Marini JC, Forlino A, Bächinger HP, et al. (2017) Osteogenesis imperfecta. Nature Reviews. Disease Primers. 3: 17052 |
Perosky JE, Khoury BM, Jenks TN, et al. (2016) Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model. Bone |
Sinder BP, Lloyd WR, Salemi JD, et al. (2016) Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age. Bone |